1,2-cyclohexanediamine has been researched along with Cancer of Ovary in 2 studies
1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yoshida, M | 1 |
Khokhar, AR | 1 |
Siddik, ZH | 1 |
Schmidt, W | 1 |
Chaney, SG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer[NCT01396707] | Phase 2 | 55 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for 1,2-cyclohexanediamine and Cancer of Ovary
Article | Year |
---|---|
Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclohexylamines; DNA, Neoplasm; Drug Resistance; Female; | 1994 |
Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclohexylamines; DNA Repair; DNA, Neoplasm; Dr | 1993 |